Surya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.10 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.99 Cr
as on 16-11-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 67.66 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.95 Cr
as on 16-11-2024
- Revenue 19.76%
(FY 2023)
- Profit 104.67%
(FY 2023)
- Ebitda 45.11%
(FY 2023)
- Net Worth 12.71%
(FY 2023)
- Total Assets 12.84%
(FY 2023)
About Surya Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.10 Cr and a paid-up capital of Rs 5.99 Cr.
The company currently has active open charges totaling ₹67.66 Cr. The company has closed loans amounting to ₹4.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yash Joshi, Arun Joshi, Neha Joshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PLC154467
- Company No.
154467
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Surya Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Joshi  | Director | 04-Jul-2005 | Current |
| Arun Joshi | Director | 04-Jul-2005 | Current |
| Neha Joshi | Director | 16-Feb-2022 | Current |
| Sandhya Joshi | Director | 04-Jul-2005 | Current |
Financial Performance of Surya Life Sciences.
Surya Life Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.76% increase. The company also saw a substantial improvement in profitability, with a 104.67% increase in profit. The company's net worth Soared by an impressive increase of 12.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surya Life Sciences?
In 2023, Surya Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Solana Life Sciences Private LimitedActive 25 years 3 monthsYash Joshi and Arun Joshi are mutual person
Griffith Overseas Private LimitedActive 8 years 2 daysYash Joshi, Arun Joshi and 2 more are mutual person
Ankleshwar Research And Analytical Infrastructure AssociationActive 19 years 6 monthsArun Joshi is a mutual person
Surya Remedies Private LimitedActive 31 years 6 monthsYash Joshi, Arun Joshi and 1 more are mutual person
- Surya Medicus Private LimitedActive 15 years 4 months
Arun Joshi and Sandhya Joshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Nov 2023 | ₹10.00 Cr | Open |
Others Creation Date: 03 Nov 2023 | ₹10.00 Cr | Open |
Axis Bank Limited Creation Date: 24 Mar 2023 | ₹2.00 Cr | Open |
How Many Employees Work at Surya Life Sciences?
Surya Life Sciences has a workforce of 64 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
